General Range
Xave-S 1.5
Price on request/100 · MOQ 100 boxes
Xave-S 1.5 Injection by Suave Healthcare Pvt. Ltd. contains Ceftriaxone and Sulbactam, a prescription injectable antibiotic combination intended for treating selected bacterial infections caused by susceptible microorganisms. Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Sulbactam helps inhibit certain beta-lactamase enzymes responsible for antibiotic resistance. Xave-S 1.5 may be prescribed for selected respiratory tract, urinary tract, skin, soft tissue, and other serious bacterial infections when combination treatment is clinically appropriate. The formulation is supplied as a 1.5 gm powder for reconstitution and administration by qualified healthcare professionals. Treatment should follow a registered medical practitioner's prescription, considering infection severity, bacterial susceptibility, patient characteristics, and verified product specifications.
CategoryGeneral Range
Min. Order100 boxes
Supplied bySuave Healthcare Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Ceftriaxone & Sulbactam for Injection IP
- Packaging Type
- Glass Vial with Carton Box and Solvent Ampoule
- Packaging Size
- 1.5 gm per vial
- Dosage Form
- Powder for Injection
- Treatment
- May be prescribed for selected bacterial respiratory infections, including pneumonia.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Suave Healthcare Pvt. Ltd.Sector 20, Panchkula, Punjab
Suave Healthcare Private Limited is an ISO 9001:2008 and WHO-GMP certified pharmaceutical company in India specializing in product manufacturing, global supply, and PCD (Propaganda Cum Distribution) franchise operations.
Company Overview
• Founded / Operational: Established in 1985 (operational since 2002) / incorporated as a private limited company.
• Headquarters / Base: Solan and Parwanoo, Himachal Pradesh, India.
• Leadership: Led by Mr. Krishan Kumar Doda (CEO).
• Certifications: ISO 9001:2008 and WHO-GMP certified manufacturing and quality standards.
Core Offerings & Services
• Product Range: Offers over 500 to 850+ formulations across diverse specialty segments.
• Product Categories: Tablets, capsules, syrups, injections, and specialized lines covering general, cardiac, diabetic, dermatological, and pediatric needs.
• Business Models:
• PCD Pharma Franchises: Provides monopoly-based territorial rights, promotional materials, and marketing support for partners across India.
• Third-Party / Contract Manufacturing: Delivers custom and bulk/hospital pharmaceutical manufacturing solutions.
More General Range
